Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sidsel Bering Olsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
-
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3
Block, I., Müller, C., Sdogati, D., Pedersen, H., List, M., Jaskot, A. M., Syse, S. D., Lund Hansen, P., Schmidt, S., Christiansen, H., Casella, C., Bering Olsen, S., Blomstrøm, M. M., Riedel, A., Thomassen, M., Kruse, T. A., Karlskov Hansen, S. W., Kioschis, P. & Mollenhauer, J., 6. Jun 2019, In: Oncogene. 38, 23, p. 4560-4573Research output: Contribution to journal › Journal article › Research › peer-review
-
Analysis of a Novel Breast Cancer Stem Cell Modulator
Olsen, S. B., 17. Jun 2016, Syddansk Universitet. Det Sundhedsvidenskabelige Fakultet. 227 p.Research output: Thesis › Ph.D. thesis
-
Construction of new cancer cell models for nanodrug discovery and testing
Hansen, P. L., Olsen, S. B., Terp, M. G., Schmidt, S., Riedel, A., Müller, C., Block, I., Christiansen, H., Ditzel, H. & Mollenhauer, J., 23. May 2011.Research output: Contribution to conference without publisher/journal › Poster › Research › peer-review
Activities
-
Identification of a Breast Cancer Stem Cell Inducer that Functions as Tumor Suppressor
Olsen, S. B. (Lecturer)
2015Activity: Talks and presentations › Talks and presentations in private or public companies
-
15th International Biennial Congress of the Metastasis Research Society
Olsen, S. B. (Participant)
28. Jun 2014 → 1. Jul 2014Activity: Attending an event › Conference organisation or participation
-
Young Investigator Satellite Meeting of the Metastasis Research Society
Olsen, S. B. (Participant)
27. Jun 2014Activity: Attending an event › Conference organisation or participation
-
Novel Metastasis and Breast Cancer Stem Cell Modulators
Olsen, S. B. (Lecturer)
2014Activity: Talks and presentations › Talks and presentations in private or public companies
-
6th European Summit for Clinical Nanomedicine & Targeted Medicine
Olsen, S. B. (Participant)
23. Jun 2013 → 27. Jun 2013Activity: Attending an event › Conference organisation or participation
Press/Media
-
MYF6 suppresses cell growth through inhibition of Akt and Wnt signaling in ER-positive breast cancer
31/01/2023
1 Media contribution
Press/Media: Press / Media
-
Human MCF7 cells engineered to overexpress MYF6 vs. Control cells containing empty vector constructs [Rec1]
31/01/2023
1 Media contribution
Press/Media: Press / Media
-
Human MCF7 cells engineered to overexpress MYF6 vs. Control cells containing empty vector constructs [Rec2]
31/01/2023
1 Media contribution
Press/Media: Press / Media